Infinium Global Research Cardiovascular Implants Market | Page 2

A latest report has been added to the wide database of Cardiovascular Implants Market by Infinium Global Research. This
report studies the Cardiovascular Implants Market by drug class (disease modifying anti-rheumatic, nonsteroidal anti-
inflammatory, corticosteroids, uric acid drugs), disease indication (rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis,
ankylosing spondylitis), distribution channel (hospital, retail, online pharmacy) market status and outlook of global and major
regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments &
countries in recent years and to forecast the values for the next six years. Cardiovascular Implants Market provides
opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape, latest
trends, and product offerings of the major companies in the Cardiovascular Implants Market. According to the report the
Global Cardiovascular Implants Market is projected to grow at a CAGR of 6.1% in terms of value over the period of 2017-2023.
CVDs include coronary artery diseases (CAD) such as angina and myocardial infarction (heart attack). Other CVDs are
peripheral arterial disease, stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart
arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous
thrombosis. There various treatment options available in the market to treat these cardiovascular diseases such as drug
therapy (ACE inhibitors, antiarrhythmic, aspirin therapy, beta-blocker therapy, clot buster drugs, diuretics, etc.), changing
lifestyle habits, and medical surgeries (stents, coronary stents, peripheral stents, heart bypass surgery, pacemakers,
implantable cardioverter defibrillators, and heart transplants). These implants are lifesaving medium to improve the patient’s
disease condition and are made of various materials, which include metals, alloys, biomaterials, and polymers.
Some of the key driving factors attributing to the growth of this include increasing number of patients with cardiovascular
diseases such as hypertension, heart failures and coronary artery diseases, and shortage of number of heart donors. In
addition, changing lifestyle, alcohol consumption, growing obesity and smoking further are propelling the market growth, as
these factors increase the bold glucose and lipid levels, which results in serious cardiovascular diseases. According to
American Heart Association publication, it has been estimated that in the US alone approximately 5.5 million people suffered
from heart failure in 2013 and 300,000 die each year because of heart failure. The market for global cardiovascular implants
was valued at USD 26.1 billion in 2015 and is expected to reach around USD 39.0 billion by 2023, growing at a CAGR of 5.8%
during the forecast period of 2017 to 2023. However, there are certain restraining factors which could hamper the growth of
the market, which includes high-risk nature and high complication rates associated with considerable mortality, due to
frequent use of implants in older populations with frequent co-morbidities. Geographically, North America is leading
contributor to the market and is expected to retain its position during the forecast period. Nonetheless, the market for Asia-
Infinium Global Research